Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
85.64 USD | +0.65% | +1.03% | +12.18% |
02:17pm | Barclays Adjusts Edwards Lifesciences Price Target to $101 From $100 | MT |
May. 01 | Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.18% | 51.28B | |
+7.96% | 219B | |
+7.20% | 183B | |
+14.82% | 136B | |
+26.56% | 107B | |
-1.14% | 63.07B | |
+7.23% | 52.55B | |
+1.62% | 41.21B | |
+5.23% | 36.43B | |
+26.01% | 31.87B |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Raymond James Adjusts Edwards Lifesciences' Price Target to $134 From $127, Keeps Outperform Rating